Answer
Breastfeeding must be discontinued throughout Campto (irinotecan) treatment because of the potential for adverse reactions in nursing infants.
Sources for this answer
- Campto 20mg/ml concentrate for solution for infusion (40mg presentation)Pfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 27Document updated
Sources checked